NIH GUIDE, Volume 25, Number 10, March 29, 1996


P.T. 34


  Grants Administration/Policy+ 



National Cancer Institute


The National Cancer Institute (NCI) announces that, with the

permission of the Office of the Director, NIH, it has established an

ongoing program to issue Shannon Awards (R55) on a three times yearly

basis to supplement and expedite the annual NIH Shannon Award

program, which is currently conducted as a single annual competition

in the last quarter of each fiscal year.


The NCI Shannon Award program will offer expedited funding for

eligible applications that otherwise might wait up to nine months for

the annual NIH Shannon competition, or for resubmission and review as

full competing amended applications.  Awardees will gain both

immediate funding to begin important and innovative research

projects; and, as has been the case for previous Shannon awards, are

likely to have improved chances for obtaining subsequent research

project grant (R01) support.


The NCI Shannon Award program is conducted under the auspices of the

authorities granted to the Director, NIH.  Terms of award will be

uniform with all other NIH Shannon Awards.  R55 awards paid with NCI

funds will be issued with the standard provisions of a 24-month

single budget period at a maximum of $100,000 total cost, with

indirect costs capped at a maximum of $20,000.


Applicants do not submit requests for Shannon Awards.  Instead, NCI

program staff nominate for award previously reviewed eligible R01,

R03, and R29 applications that are beyond the current NCI payline.

After each of the three review cycles per year, Shannon Award

nominations will be administratively reviewed by NCI according to

standard review criteria, then submitted to the Office of Extramural

Research, NIH, for expedited review and concurrence prior to funding.


The NCI will use NCI funds to award R55 nominations that become

eligible after each of the first two National Advisory Board rounds

in each fiscal year.  Such nominations cannot now be considered in a

timely way, given the single annual summer date of the NIH-wide

Shannon competition supported from the NIH Director's Discretionary

Fund.  The third round of the year will be submitted under the

auspices of the current NIH-wide Shannon Award program.


If the NIH is not able to hold a Shannon competition in a given year,

NCI will extend its own program to all three application review

rounds.  The NCI is committed to offer funding for Shannon awards in

numbers substantially higher than have previously been possible.  It

is anticipated that NCI will be able to commit approximately

$3,000,000 to the NCI Shannon Award program in FY 96.


NCI's continuation of this program in the future is contingent upon

the availability of appropriated funds and applications of sufficient

scientific merit.




For specific questions on this process, nominees may contact the NCI

program director indicated on the original summary statement.

General policy questions may be directed to:


Marvin R. Kalt, Ph.D.

Director, Division of Extramural Activities

National Cancer Institute

6130 Executive Boulevard, Suite 600 - MSC 7405

Bethesda, MD  20892-7405



Inquiries of a fiscal/administrative nature may be directed to:


Ms. Catherine Blount

Grants Administration Branch

National Cancer Institute

6120 Executive Boulevard, Suite 243

Bethesda, MD  20892

Telephone:  (301) 496-7800, ext. 262



Return to 1996 Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.